Lori Firmani
Fortuna: 23 163 $ al 31/05/2026
Fortuna: 23 163 $ al 31/05/2026
Lori Firmani worked as Chief Financial & Accounting Officer at F-Star Therapeutics, Inc. in 2020.
Ms. Firmani worked as Chief Financial & Accounting Officer at Damora Therapeutics, Inc. from 2024 to 2026.
Ms. Firmani earned an MBA from Babson College and completed undergraduate studies at the State University of New York College at Geneseo.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 22/04/2026 | 931 ( 0 % ) | 23 163 $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Director Financiero/CFO | 01/05/2026 |
| SPRING BANK PHARMACEUTICALS, INC. | Director Financiero/CFO | 20/11/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Babson College
Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York College at Geneseo
State University of New York College at Geneseo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-Star Therapeutics, Inc. (United States)
F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Galecto, Inc.
Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.